Shufro Rose & CO LLC Amgen Inc Transaction History

Shufro Rose & CO LLC

$1.27 Billion
Q3 2024

A detailed history of Shufro Rose & CO LLC transactions in Amgen Inc stock. As of the latest transaction made, Shufro Rose & CO LLC holds 41,736 shares of AMGN stock, worth $11 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

41,736

Previous 41,736 -0.0%

Holding current value

$11 Million

Previous $13 Million 3.12%

% of portfolio

1.06%

Previous 1.07%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $105,100 - $127,724	-400 Reduced 0.95%	41,736 $13 Million
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $33,071 - $39,920	-123 Reduced 0.29%	42,136 $12 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $121,968 - $137,595	-477 Reduced 1.12%	42,259 $12.2 Million
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $46,572 - $57,820	-213 Reduced 0.5%	42,736 $11.5 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $179,558 - $212,324	-838 Reduced 1.91%	42,949 $9.54 Million
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $321,976 - $392,435	-1,426 Reduced 3.15%	43,787 $10.6 Million
Q4 2022 Jan 25, 2023	SELL	$229.03 - $291.01 $566,849 - $720,249	-2,475 Reduced 5.19%	45,213 $0
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $3,815 - $4,303	-17 Reduced 0.04%	47,688 $10.7 Million
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $6,229 - $6,931	27 Added 0.06%	47,705 $11.6 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $318,380 - $352,211	-1,452 Reduced 2.96%	47,678 $11.5 Million
Q4 2021 Jan 27, 2022	SELL	$198.88 - $227.6 $344,460 - $394,203	-1,732 Reduced 3.41%	49,130 $11.1 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $305,031 - $357,381	-1,437 Reduced 2.75%	50,862 $10.8 Million
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $114,454 - $126,978	-490 Reduced 0.93%	52,299 $12.7 Million
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $83,216 - $96,975	-375 Reduced 0.71%	52,789 $13.1 Million
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $1.91 Million - $2.28 Million	-8,832 Reduced 14.25%	53,164 $12.2 Million
Q3 2020 Oct 27, 2020	SELL	$234.65 - $260.95 $275,244 - $306,094	-1,173 Reduced 1.86%	61,996 $15.8 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $3.54 Million - $4.34 Million	-17,885 Reduced 22.07%	63,169 $14.9 Million
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $1.66 Million - $2.2 Million	-9,086 Reduced 10.08%	81,054 $16.4 Million
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $307,655 - $395,443	-1,626 Reduced 1.77%	90,140 $21.7 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $177,418 - $212,583	-1,019 Reduced 1.1%	91,766 $17.8 Million
Q2 2019 Jul 24, 2019	BUY	$166.7 - $195.41 $2.15 Million - $2.52 Million	12,885 Added 16.13%	92,785 $17.1 Million
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $303,318 - $341,906	-1,677 Reduced 2.06%	79,900 $15.2 Million
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $265,102 - $309,459	-1,486 Reduced 1.79%	81,577 $15.9 Million
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $249,770 - $281,583	-1,348 Reduced 1.6%	83,063 $17.2 Million
Q2 2018 Jul 27, 2018	SELL	$166.05 - $186.51 $123,873 - $139,136	-746 Reduced 0.88%	84,411 $15.6 Million
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $2.46 Million - $2.87 Million	-14,506 Reduced 14.56%	85,157 $14.5 Million
Q4 2017 Feb 06, 2018	SELL	$168.79 - $188.59 $57,894 - $64,686	-343 Reduced 0.34%	99,663 $17.3 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $16.7 Million - $19.1 Million	100,006	100,006 $18.6 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shufro Rose & CO LLC with notifications on news.

Account

Shufro Rose & CO LLC Amgen Inc Transaction History